Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
出版年份 2015 全文链接
标题
Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
作者
关键词
-
出版物
Cancers
Volume 7, Issue 4, Pages 2290-2308
出版商
MDPI AG
发表日期
2015-11-18
DOI
10.3390/cancers7040890
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma chromogranin A: Clinical implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy
- (2017) Debansu Sarkar et al. Cancer Biomarkers
- Telomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages
- (2016) Jayant K. Rane et al. EUROPEAN UROLOGY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Patients
- (2015) Arun A. Azad et al. EUROPEAN UROLOGY
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Cancer stem cells, cancer cell plasticity and radiation therapy
- (2015) Erina Vlashi et al. SEMINARS IN CANCER BIOLOGY
- Enzalutamide for patients with metastatic castration-resistant prostate cancer
- (2015) Wijdan Ramadan et al. OncoTargets and Therapy
- Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells
- (2015) Xin Liu et al. Oncotarget
- CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells
- (2015) Norihiko Kawamura et al. Oncotarget
- A switch from CD44+ cell to EMT cell drives the metastasis of prostate cancer
- (2015) Zhiqun Shang et al. Oncotarget
- Epigenomic Alterations in Localized and Advanced Prostate Cancer
- (2015) Pei-Chun Lin et al. NEOPLASIA
- Novel drugs targeting the androgen receptor pathway in prostate cancer
- (2014) Joaquin Mateo et al. CANCER AND METASTASIS REVIEWS
- The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
- (2014) Rhonda L. Bitting et al. CANCER AND METASTASIS REVIEWS
- DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation
- (2014) D Pellacani et al. CELL DEATH AND DIFFERENTIATION
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone
- (2014) Salvatore Luca Burgio et al. ENDOCRINE-RELATED CANCER
- Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response
- (2014) Judy Yan et al. EXPERIMENTAL CELL RESEARCH
- Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
- (2014) Barbara Kahn et al. International Journal of Biological Sciences
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Evolution of androgen receptor targeted therapy for advanced prostate cancer
- (2014) Yien Ning Sophia Wong et al. Nature Reviews Clinical Oncology
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
- (2014) Vincenza Conteduca et al. PROSTATE
- The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells
- (2014) Steven Kregel et al. PROSTATE
- Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes
- (2014) Dejuan Kong et al. PROSTATE
- Plasticity of epithelial stem cells in tissue regeneration
- (2014) C. Blanpain et al. SCIENCE
- Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy
- (2014) KATSUHITO MIYAZAWA et al. Oncology Letters
- Symmetrical and asymmetrical division analysis provides evidence for a hierarchy of prostate epithelial cell lineages
- (2014) Jia Wang et al. Nature Communications
- Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells
- (2014) Ying-Chu Lin et al. Stem Cell Research & Therapy
- Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
- (2014) Mannan Nouri et al. Frontiers in Oncology
- Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
- (2013) K. L. Noonan et al. ANNALS OF ONCOLOGY
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- HDAC inhibitor confers radiosensitivity to prostate stem-like cells
- (2013) F M Frame et al. BRITISH JOURNAL OF CANCER
- Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
- (2013) A. Schroeder et al. CANCER RESEARCH
- JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
- (2013) P. Kroon et al. CANCER RESEARCH
- Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
- (2013) L.-Y. Fang et al. CANCER RESEARCH
- A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
- (2013) N. Mitsiades CANCER RESEARCH
- Generation of Prostate Tumor-Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling
- (2013) Y. Qu et al. CANCER RESEARCH
- New insights into prostate cancer stem cells
- (2013) Xin Chen et al. CELL CYCLE
- SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells
- (2013) Adrian P. Rybak et al. CELLULAR SIGNALLING
- Wnt signaling in adult intestinal stem cells and cancer
- (2013) Michaela Krausova et al. CELLULAR SIGNALLING
- Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
- (2013) D. Bianchini et al. EUROPEAN JOURNAL OF CANCER
- Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
- (2013) Andres Jan Schrader et al. EUROPEAN UROLOGY
- Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
- (2013) Prabhakar Rajan et al. EUROPEAN UROLOGY
- Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6
- (2013) Jen-Tsun Lin et al. EXPERIMENTAL CELL RESEARCH
- Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis
- (2013) Tzu-Hua Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
- (2013) Murielle Mimeault et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activation of the Wnt Pathway through AR79, a GSK3 Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
- (2013) Y. Jiang et al. MOLECULAR CANCER RESEARCH
- Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity
- (2013) Zhu A. Wang et al. NATURE CELL BIOLOGY
- Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
- (2013) J L L Robinson et al. ONCOGENE
- Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
- (2013) Steven Kregel et al. PLoS One
- Enrichment of putative prostate cancer stem cells after androgen deprivation: Upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines
- (2013) Daniel Seiler et al. PROSTATE
- Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells
- (2013) Chengfei Liu et al. PROSTATE
- Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting
- (2013) Kenneth J. Pienta et al. PROSTATE
- Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
- (2013) M. A. Nieto SCIENCE
- Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
- (2013) T-H Lin et al. Cell Death & Disease
- Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer
- (2013) C. J. Logothetis et al. Cancer Discovery
- Interplay Between Genomic Alterations and Androgen Receptor Signaling During Prostate Cancer Development and Progression
- (2013) Michael D. Nyquist et al. Hormones & Cancer
- An APC:WNT Counter-Current-Like Mechanism Regulates Cell Division Along the Human Colonic Crypt Axis: A Mechanism That Explains How APC Mutations Induce Proliferative Abnormalities That Drive Colon Cancer Development
- (2013) Bruce M. Boman et al. Frontiers in Oncology
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk
- (2012) Erika M. Kwon et al. Cancer Epidemiology
- Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
- (2012) N. Mitsiades et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Progress in emerging therapies for advanced prostate cancer
- (2012) Stéphane Oudard CANCER TREATMENT REVIEWS
- MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway
- (2012) I-Shan Hsieh et al. CARCINOGENESIS
- The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
- (2012) Jichao Qin et al. Cell Stem Cell
- Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression
- (2012) E. Levesque et al. CLINICAL CANCER RESEARCH
- Cancer stem cells as ‘units of selection’
- (2012) Mel Greaves Evolutionary Applications
- Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration
- (2012) Antonella De Luca et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stem-Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer
- (2012) Markus Germann et al. STEM CELLS
- Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention
- (2012) Shidong Jia et al. Cancer Discovery
- Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells
- (2011) Adrian P. Rybak et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
- (2011) Y. Sun et al. CANCER RESEARCH
- HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
- (2011) J. Mathieu et al. CANCER RESEARCH
- STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
- (2011) L. Lin et al. CANCER RESEARCH
- Sox2+ Adult Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival of Mice
- (2011) Katrin Arnold et al. Cell Stem Cell
- FOXA1: master of steroid receptor function in cancer
- (2011) Michael A Augello et al. EMBO JOURNAL
- Alternatively spliced androgen receptor variants
- (2011) Scott M Dehm et al. ENDOCRINE-RELATED CANCER
- Molecular genetics of prostate cancer: emerging appreciation of genetic complexity
- (2011) Christopher E Barbieri et al. HISTOPATHOLOGY
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
- (2011) C R Jeter et al. ONCOGENE
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
- (2011) A. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
- (2011) D. Iliopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases
- (2011) Marc Colombel et al. PROSTATE
- Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
- (2011) Mohamed Salem et al. Current Oncology Reports
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- CYP17 inhibitors for prostate cancer therapy
- (2010) Tadas S. Vasaitis et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
- (2010) Michael C Haffner et al. NATURE GENETICS
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
- (2010) Hiroshi Tanaka et al. NATURE MEDICINE
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
- (2009) Isabelle Bisson et al. CELL RESEARCH
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
- (2009) George J. Klarmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1α Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
- (2009) Carol L. Nilsson et al. JOURNAL OF PROTEOME RESEARCH
- Linking the p53 tumour suppressor pathway to somatic cell reprogramming
- (2009) Teruhisa Kawamura et al. NATURE
- A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
- (2009) Rosa M. Marión et al. NATURE
- Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
- (2009) Jochen Utikal et al. NATURE
- The Ink4/Arf locus is a barrier for iPS cell reprogramming
- (2009) Han Li et al. NATURE
- Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
- (2009) Wennuan Liu et al. NATURE MEDICINE
- Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
- (2009) Ganesh S. Palapattu et al. PROSTATE
- Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
- (2009) R.-S. Mani et al. SCIENCE
- Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
- (2009) Hui Wang et al. STEM CELLS
- Current status of experimental therapeutics for prostate cancer
- (2008) Chulso Moon et al. CANCER LETTERS
- Crosstalk between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer
- (2008) G. Wang et al. CANCER RESEARCH
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells
- (2007) Hongzhen Li et al. EXPERIMENTAL CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now